Ultrafast CT developer Imatron has revised its product development and distribution agreementwith Siemens, the South San Francisco, CA, company reported lastweek. Under the terms of the new deal, Siemens will contribute$15 million toward a three-year
Ultrafast CT developer Imatron has revised its product development and distribution agreementwith Siemens, the South San Francisco, CA, company reported lastweek. Under the terms of the new deal, Siemens will contribute$15 million toward a three-year collaborative research programto upgrade Imatron's C-150 CT scanner, marketed by Siemens asEvolution EBT. Siemens will also cancel a $4 million loan to Imatronfor the transfer of Imatron patents to Siemens.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.